Research Progress of Pyroptosis in Renal Diseases
- PMID: 37861024
- DOI: 10.2174/0109298673255656231003111621
Research Progress of Pyroptosis in Renal Diseases
Abstract
Kidney diseases, particularly Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD), are identified as global public health issues affecting millions of individuals. In addition, the frequency of renal diseases in the population has increased dramatically and rapidly in recent years. Renal disorders have become a significant public health burden. The pathophysiology of renal diseases is significantly connected with renal cell death, including apoptosis, necrosis, necroptosis, ferroptosis, pyroptosis, and autophagy, as is now recognized. Unlike other forms of cell death, pyroptosis is a unique planned cell death (PCD). Scientists have proven that pyroptosis is crucial in developing various disorders, and this phenomenon is gaining increasing attention. It is considered a novel method of inflammatory cell death. Intriguingly, inflammation is among the most significant pathological characteristics of renal disease. This study investigates the effects of pyroptosis on Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Diabetic Nephropathy (DN), Immunoglobulin A (IgA) Nephropathy, and Lupus Nephritis (LN) to identify novel therapeutic targets for kidney diseases.
Keywords: Pyroptosis; acute kidney injury; chronic kidney disease; diabetic nephropathy; kidney disease; lupus nephritis..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Pathological spectrum of glomerular disease in patients with renal insufficiency: a single-center study in Northeastern China.Ren Fail. 2019 Nov;41(1):473-480. doi: 10.1080/0886022X.2019.1620774. Ren Fail. 2019. PMID: 31198075 Free PMC article.
-
The role of IL-10 in kidney disease.Int Immunopharmacol. 2022 Jul;108:108917. doi: 10.1016/j.intimp.2022.108917. Epub 2022 Jun 3. Int Immunopharmacol. 2022. PMID: 35729842 Review.
-
Disease spectrum of 9 310 cases of renal biopsy pathological diagnosis from a single center in China.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 May 28;47(5):546-554. doi: 10.11817/j.issn.1672-7347.2022.210487. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35753724 Free PMC article. Chinese, English.
-
Glomerulonephritis Histopathological Pattern Change.BMC Nephrol. 2020 May 18;21(1):186. doi: 10.1186/s12882-020-01836-3. BMC Nephrol. 2020. PMID: 32423387 Free PMC article.
-
Copper-instigated modulatory cell mortality mechanisms and progress in kidney diseases.Ren Fail. 2025 Dec;47(1):2431142. doi: 10.1080/0886022X.2024.2431142. Epub 2025 Jan 13. Ren Fail. 2025. PMID: 39805816 Free PMC article. Review.
Cited by
-
Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases.Cell Death Dis. 2024 Jul 4;15(7):481. doi: 10.1038/s41419-024-06807-2. Cell Death Dis. 2024. PMID: 38965216 Free PMC article. Review.
References
-
- Galluzzi L.; Vitale I.; Aaronson S.A.; Abrams J.M.; Adam D.; Agostinis P.; Alnemri E.S.; Altucci L.; Amelio I.; Andrews D.W.; Annicchiarico-Petruzzelli M.; Antonov A.V.; Arama E.; Baehrecke E.H.; Barlev N.A.; Bazan N.G.; Bernassola F.; Bertrand M.J.M.; Bianchi K.; Blagosklonny M.V.; Blomgren K.; Borner C.; Boya P.; Brenner C.; Campanella M.; Candi E.; Carmona-Gutierrez D.; Cecconi F.; Chan F.K.M.; Chandel N.S.; Cheng E.H.; Chipuk J.E.; Cidlowski J.A.; Ciechanover A.; Cohen G.M.; Conrad M.; Cubillos-Ruiz J.R.; Czabotar P.E.; D’Angiolella V.; Dawson T.M.; Dawson V.L.; De Laurenzi V.; De Maria R.; Debatin K.M.; DeBerardinis R.J.; Deshmukh M.; Di Daniele N.; Di Virgilio F.; Dixit V.M.; Dixon S.J.; Duckett C.S.; Dynlacht B.D.; El-Deiry W.S.; Elrod J.W.; Fimia G.M.; Fulda S.; García-Sáez A.J.; Garg A.D.; Garrido C.; Gavathiotis E.; Golstein P.; Gottlieb E.; Green D.R.; Greene L.A.; Gronemeyer H.; Gross A.; Hajnoczky G.; Hardwick J.M.; Harris I.S.; Hengartner M.O.; Hetz C.; Ichijo H.; Jäättelä M.; Joseph B.; Jost P.J.; Juin P.P.; Kaiser W.J.; Karin M.; Kaufmann T.; Kepp O.; Kimchi A.; Kitsis R.N.; Klionsky D.J.; Knight R.A.; Kumar S.; Lee S.W.; Lemasters J.J.; Levine B.; Linkermann A.; Lipton S.A.; Lockshin R.A.; López-Otín C.; Lowe S.W.; Luedde T.; Lugli E.; MacFarlane M.; Madeo F.; Malewicz M.; Malorni W.; Manic G.; Marine J.C.; Martin S.J.; Martinou J.C.; Medema J.P.; Mehlen P.; Meier P.; Melino S.; Miao E.A.; Molkentin J.D.; Moll U.M.; Muñoz-Pinedo C.; Nagata S.; Nuñez G.; Oberst A.; Oren M.; Overholtzer M.; Pagano M.; Panaretakis T.; Pasparakis M.; Penninger J.M.; Pereira D.M.; Pervaiz S.; Peter M.E.; Piacentini M.; Pinton P.; Prehn J.H.M.; Puthalakath H.; Rabinovich G.A.; Rehm M.; Rizzuto R.; Rodrigues C.M.P.; Rubinsztein D.C.; Rudel T.; Ryan K.M.; Sayan E.; Scorrano L.; Shao F.; Shi Y.; Silke J.; Simon H.U.; Sistigu A.; Stockwell B.R.; Strasser A.; Szabadkai G.; Tait S.W.G.; Tang D.; Tavernarakis N.; Thorburn A.; Tsujimoto Y.; Turk B.; Vanden Berghe T.; Vandenabeele P.; Vander Heiden M.G.; Villunger A.; Virgin H.W.; Vousden K.H.; Vucic D.; Wagner E.F.; Walczak H.; Wallach D.; Wang Y.; Wells J.A.; Wood W.; Yuan J.; Zakeri Z.; Zhivotovsky B.; Zitvogel L.; Melino G.; Kroemer G.; Molecular mechanisms of cell death: Recommendations of the nomenclature committee on cell death 2018. Cell Death Differ 2018,25(3),486-541 - DOI - PubMed
-
- Kayagaki N.; Stowe I.B.; Lee B.L.; O’Rourke K.; Anderson K.; Warming S.; Cuellar T.; Haley B.; Roose-Girma M.; Phung Q.T.; Liu P.S.; Lill J.R.; Li H.; Wu J.; Kummerfeld S.; Zhang J.; Lee W.P.; Snipas S.J.; Salvesen G.S.; Morris L.X.; Fitzgerald L.; Zhang Y.; Bertram E.M.; Goodnow C.C.; Dixit V.M.; Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 2015,526(7575),666-671 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous